FDAnews Drug Daily Bulletin

ArQule Says Partner Halts Cancer Drug Trial, Shares Slide

Aug. 31, 2012
A A
Biotechnology company ArQule said Japan’s Kyowa Hakko Kirin Co, which holds development rights to an ArQule cancer drug in parts of Asia, suspended patient enrollment in a late-stage trial to treat lung cancer.
Reuters